Micron reports Q3 FY2026 results on 24 June, with consensus projecting 283% revenue growth and record 81.6% gross margins.
Micron Technology will report its fiscal third-quarter (Q3) 2026 results on Wednesday 24 June, after market close.
Micron's fiscal second quarter delivered a comprehensive sweep of company records. Revenue of $23.9 billion represented 196% year-on-year (YoY) growth — the fourth consecutive quarterly record and the largest sequential dollar increase in the company's history.
DRAM contributed 79% of revenue at $18.8 billion (+207% YoY), with prices rising by a mid-60s percentage quarter-on-quarter (QoQ). NAND contributed $5.0 billion (+169% YoY), with prices up by a high-70s percentage.
The severity of the supply constraint was underscored by chief executive Sanjay Mehrotra's disclosure that Micron can fulfil only 50% to two-thirds of customer demand in the medium term — a structural supply deficit that continues to amplify pricing power. Gross margin reached a company record of 74.9%, nearly double the year-ago level. Adjusted free cash flow of $6.9 billion — also a record — funded $1.6 billion in debt reduction and a 30% dividend increase.
LSEG consensus projects Q3 revenue of $35.59 billion, exceeding the top end of management's guided range of $32.75–$34.25 billion and implying a further acceleration from Q2's already-exceptional 196% pace. DRAM remains the primary growth engine, expected to account for approximately 77% of total revenue. Consensus gross margin of 81.6% — which would be the highest in company history if achieved — is broadly consistent with management's 81% guidance, reflecting continued pricing power in a structurally undersupplied market. The bar is elevated: a guidance beat alone may not satisfy investors who are already pricing in an extended memory super cycle.
|
Q3 2025 (actual) |
Q3 2026 (estimated) |
YoY change |
Total revenue |
$9,301 million |
$35,590 million |
+282.6% |
DRAM |
$7,071 million |
$27,227 million |
+285.1% |
NAND |
$2,155 million |
$7,807 million |
+262.3% |
Non-GAAP net income |
$2,181 million |
$23,428 million |
+974.2% |
Gross margin |
39.0% |
81.6% |
+42.6 pp |
Source: LSEG
Wall Street carries a near-consensus bullish stance on Micron. Of 27 analysts tracked by TipRanks, 25 carry a buy-equivalent rating, with two holds and no sells. The average 12-month price target of $1,246 implies only 2.9% upside from the 22 June closing price — a narrow premium for a stock that has already rallied 324% year-to-date.
The most bullish target on the Street stands at $1,750, while the most conservative sits at $400 — issued in January, prior to the bulk of the year-to-date rally.
With options markets pricing a 13% expected move into Wednesday's result, the critical question is less about whether Micron beats Q3 consensus and more about whether Q4 guidance and 2027 supply commentary can justify a valuation that has already crossed $1 trillion in market capitalisation.
Micron's share price has surged 285% since bottoming at $311.50 on 31 March, though the rally has been punctuated by two sharp pullbacks of approximately 20% each in mid-May and early June — underscoring the stock's susceptibility to abrupt reversals despite its strong underlying momentum.
The stock currently trades well above all three moving averages (MA), confirming the prevailing bullish trend. Key support is identified at $1,089, the peak of the prior advance. On the upside, the 61.8% Fibonacci extension under Elliott Wave theory points to a target of $1,335. However, with the relative strength index (RSI) approaching overbought territory, the margin for error is limited — even a strong result may prove insufficient to prevent profit-taking at current levels.
The figures stated are as of 23 June 2026 unless otherwise stated. Past performance is not a reliable indicator of future performance.
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.